Excellos Selected as Decentralized Manufacturing Unit to Support Galapagos’ CAR-T Cell Therapy
Excellos Selected as Decentralized Manufacturing Unit to Support Galapagos’ CAR-T Cell Therapy Clinical Study Close to Cancer Treatment Centers in the San Diego Area Excellos is the first decentralized manufacturing unit (DMU) within the nationwide network of Blood Centers of America to be selected for Good Manufacturing Compliant (GMP) manufacturing for Galapagos’ CAR-T hemato-oncology […]
Thomas VanCott joins Excellos as new CEO
Excellos Announces Acceleration of Commercialization, New CEO, Thomas VanCott New investment funds expansion of commercial team SAN DIEGO. CA, May 7, 2024, – Excellos Inc., a cell therapy contract and development manufacturing organization (CDMO), today announced it had taken additional investment to accelerate commercialization efforts. As part of the change new CEO Thomas VanCott, Ph.D., […]
Excellos Announces Strategic Partnership and Investment from Vitalant
Strategic Partnership With Vitalant to Bring Better Therapies to Patients Partnership to deliver enhanced donor profiles for higher potency cell therapeutics SAN DIEGO. CA, January 17, 2024, – Excellos Inc., a cell therapy contract and development manufacturing organization (CDMO), today announced a new partnership with Vitalant, one of the nation’s largest nonprofit blood and biotherapies […]
Excellos Opens Cutting-Edge Cell Therapy GMP Manufacturing Facility in Downtown San Diego
June 27, 2023; San Diego, California – Excellos Opens Cutting-Edge Cell Therapy GMP Manufacturing Facility in Downtown San Diego. Cell Therapy GMP Manufacturing Facility Excellos, a full-service contract development and manufacturing organization (CDMO) for cell therapy, proudly announces the opening of their cell therapy GMP manufacturing facility in the heart of downtown San Diego. The facility […]
Excellos Launches ‘Excellos 360’ Alongside RUO and GMP Product Portfolio to Reduce Clinical Response Variability
The central aims of Excellos 360 are to reduce clinical response variability and possibly improve outcomes, lower safety liability by allowing effectiveness in lower dosages and reducing the cost of goods associated with advanced therapies. January 17, 2023; San Diego, California – Excellos, the California-based, full-service CDMO, has today announced the launch of ‘Excellos 360’, […]
Genesis San Diego Secures Excellos, Marking Downtown San Diego’s Second-Ever Life Sciences Lab Lease
CHARLOTTE, N.C. and SAN DIEGO, Oct. 26, 2022 /PRNewswire/ — Barings, one of the world’s largest diversified real estate investment managers, along with Phase 3 Real Estate Partners and Bain Capital Real Estate, announced today that their joint venture has secured Excellos as a tenant at Genesis San Diego, a premier Class A life science […]
And Blast off……Excellos Launches into (Cell Therapy) Space
The launch of Excellos now brings scientific and cell manipulation expertise to support the development of investigational cellular products through to commercialization, by leveraging the San Diego Blood Bank (SDBB) and its network of collection centers.
Cell and Gene Therapy Industry – Excellos Launches to Accelerate Innovation
Founded by an Experienced Management Team and Built on the Reach and Infrastructure of the San Diego Blood Bank Cell and Gene Therapy CDMO San Diego, CA: Excellos, Incorporated, a cell therapy Contract Development and Manufacturing Organization (CDMO), announces its official corporate launch and closing of $15M in growth funding from Telegraph Hill Partners (THP). […]